Quanfeng Zhao
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study.
Journal: Frontiers in immunology
Published: February 11, 2026
A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS).
Journal: Frontiers in pharmacology
Published: March 22, 2024
Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data.
Journal: Frontiers in pharmacology
Published: July 09, 2022
Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data.
Journal: Frontiers in pharmacology
Published: April 04, 2022
Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation.
Journal: Frontiers in pharmacology
Published: November 19, 2021
A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy.
Journal: Frontiers in pharmacology
Published: November 09, 2021
Discovery of Potent and Isoform-selective Histone Deacetylase Inhibitors Using Structure-based Virtual Screening and Biological Evaluation.
Journal: Molecular informatics
Published: October 29, 2021
Inhibition of COX2/PGD2-Related Autophagy Is Involved in the Mechanism of Brain Injury in T2DM Rat.
Journal: Frontiers in cellular neuroscience
Published: August 03, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026